日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Genomic profiling of idiopathic peri-hilar cholangiocarcinoma reveals new targets and mutational pathways

特发性肝门部胆管癌的基因组分析揭示了新的靶点和突变通路

Quinn, Leonard M; Haldenby, Sam; Antzcak, Philip; Fowler, Anna; Bullock, Katie; Kenny, John; Gilbert, Timothy; Andrews, Timothy; Diaz-Nieto, Rafael; Fenwick, Stephen; Jones, Robert; Costello-Goldring, Eithne; Poston, Graeme; Greenhalf, William; Palmer, Daniel; Malik, Hassan; Goldring, Chris

Characterisation of SARS-CoV-2 genomic variation in response to molnupiravir treatment in the AGILE Phase IIa clinical trial.

在 AGILE IIa 期临床试验中,对 SARS-CoV-2 基因组变异对 molnupiravir 治疗的反应进行表征

Donovan-Banfield I'ah, Penrice-Randal Rebekah, Goldswain Hannah, Rzeszutek Aleksandra M, Pilgrim Jack, Bullock Katie, Saunders Geoffrey, Northey Josh, Dong Xiaofeng, Ryan Yan, Reynolds Helen, Tetlow Michelle, Walker Lauren E, FitzGerald Richard, Hale Colin, Lyon Rebecca, Woods Christie, Ahmad Shazaad, Hadjiyiannakis Dennis, Periselneris Jimstan, Knox Emma, Middleton Calley, Lavelle-Langham Lara, Shaw Victoria, Greenhalf William, Edwards Thomas, Lalloo David G, Edwards Christopher J, Darby Alistair C, Carroll Miles W, Griffiths Gareth, Khoo Saye H, Hiscox Julian A, Fletcher Thomas

Pharmacokinetics of ß-d-N4-Hydroxycytidine, the Parent Nucleoside of Prodrug Molnupiravir, in Nonplasma Compartments of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection

β-d-N4-羟基胞苷(前药莫努匹拉韦的母核苷)在重症急性呼吸综合征冠状病毒2感染患者非血浆隔室中的药代动力学

FitzGerald, Richard; Dickinson, Laura; Else, Laura; Fletcher, Thomas; Hale, Colin; Amara, Alieu; Walker, Lauren; Penchala, Sujan Dilly; Lyon, Rebecca; Shaw, Victoria; Greenhalf, William; Bullock, Katie; Lavelle-Langham, Lara; Reynolds, Helen; Painter, Wendy; Holman, Wayne; Ewings, Sean; Griffiths, Gareth; Khoo, Saye